Highest Frequencies of Interleukin-22-Producing T Helper Cells in Alcoholic Hepatitis Patients with a Favourable Short-Term Course

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Støy, Sidsel ^a   Sandahl, Thomas Damgaard ^a   Dige, Anders Kirch ^a   Agnholt, Jørgen ^a   Rasmussen, Tue Kruse ^b   Grønbæk, Henning ^a   Deleuran, Bent ^b   Vilstrup, Hendrik ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD45RO ANTIGEN; INTERLEUKIN 17; INTERLEUKIN 21; INTERLEUKIN 22; INTERLEUKIN 23;

ADULT; ALCOHOL LIVER CIRRHOSIS; ALCOHOL LIVER DISEASE; ARTICLE; CD4+ T LYMPHOCYTE; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE COURSE; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; GENERAL CONDITION IMPROVEMENT; GLASGOW ALCOHOLIC HEPATITIS SCORE; HUMAN; HUMAN CELL; LYMPHOCYTE DIFFERENTIATION; MALE; PROTEIN BLOOD LEVEL; SCORING SYSTEM; SHORT COURSE THERAPY; TH17 CELL;

ADULT; AGED; ANTIGENS, CD4; ANTIGENS, CD45; FEMALE; HEPATITIS, ALCOHOLIC; HUMANS; INTERLEUKIN-17; INTERLEUKIN-23; INTERLEUKINS; MALE; MIDDLE AGED; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 84872849622     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0055101     Document Type: Article

References (43)

1. Sandahl TD, Jepsen P, Thomsen KL, Vilstrup H (2011) Incidence and mortality of alcoholic hepatitis in Denmark 1999-2008: a nationwide population based cohort study. J Hepatol 54: 760-764. Epub 2010 Sep 2019.
2. Lucey MR, Mathurin P, Morgan TR, (2009) Alcoholic hepatitis. N Engl J Med 360: 2758-2769.
3. Fujimoto M, Uemura M, Nakatani Y, Tsujita S, Hoppo K, et al. (2000) Plasma endotoxin and serum cytokine levels in patients with alcoholic hepatitis: relation to severity of liver disturbance. Alcohol Clin Exp Res 24: 48S-54S.
4. Keshavarzian A, Holmes EW, Patel M, Iber F, Fields JZ, et al. (1999) Leaky gut in alcoholic cirrhosis: a possible mechanism for alcohol-induced liver damage. Am J Gastroenterol 94: 200-207.
5. Mookerjee RP, Stadlbauer V, Lidder S, Wright GA, Hodges SJ, et al. (2007) Neutrophil dysfunction in alcoholic hepatitis superimposed on cirrhosis is reversible and predicts the outcome. Hepatology 46: 831-840.
6. Lefkowitch JH, (2005) Morphology of alcoholic liver disease. Clin Liver Dis 9: 37-53.
7. Ziol M, Tepper M, Lohez M, Arcangeli G, Ganne N, et al. (2001) Clinical and biological relevance of hepatocyte apoptosis in alcoholic hepatitis. J Hepatol 34: 254-260.
8. Zenewicz LA, Yancopoulos GD, Valenzuela DM, Murphy AJ, Karow M, et al. (2007) Interleukin-22 but not interleukin-17 provides protection to hepatocytes during acute liver inflammation. Immunity 27: 647-659. Epub 2007 Oct 2004.
9. Wolk K, Kunz S, Asadullah K, Sabat R, (2002) Cutting edge: immune cells as sources and targets of the IL-10 family members? J Immunol 168: 5397-5402.
10. Sonnenberg GF, Fouser LA, Artis D, (2011) Border patrol: regulation of immunity, inflammation and tissue homeostasis at barrier surfaces by IL-22. Nat Immunol 12: 383-390.
11. Volpe E, Touzot M, Servant N, Marloie-Provost MA, Hupe P, et al. (2009) Multiparametric analysis of cytokine-driven human Th17 differentiation reveals a differential regulation of IL-17 and IL-22 production. Blood 114: 3610-3614. Epub 2009 Aug 3624.
12. Eyerich S, Eyerich K, Pennino D, Carbone T, Nasorri F, et al. (2009) Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling. J Clin Invest 119: 3573-3585 doi:3510.1172/JCI40202. Epub 42009 Nov 40216.
13. Wolk K, Kunz S, Witte E, Friedrich M, Asadullah K, et al. (2004) IL-22 increases the innate immunity of tissues. Immunity 21: 241-254.
14. Brand S, Dambacher J, Beigel F, Zitzmann K, Heeg MH, et al. (2007) IL-22-mediated liver cell regeneration is abrogated by SOCS-1/3 overexpression in vitro. Am J Physiol Gastrointest Liver Physiol 292: G1019-1028. Epub 2007 Jan 1014.
15. Ren X, Hu B, Colletti LM (2010) IL-22 is involved in liver regeneration after hepatectomy. Am J Physiol Gastrointest Liver Physiol 298: G74-80. Epub 2009 Oct 2029.
16. Park O, Wang H, Weng H, Feigenbaum L, Li H, et al. (2011) In vivo consequences of liver-specific interleukin-22 expression in mice: Implications for human liver disease progression. Hepatology 54: 252-261 doi:210.1002/hep.24339.
17. Ki SH, Park O, Zheng M, Morales-Ibanez O, Kolls JK, et al. (2010) Interleukin-22 treatment ameliorates alcoholic liver injury in a murine model of chronic-binge ethanol feeding: role of signal transducer and activator of transcription 3. Hepatology 52: 1291-1300.
18. Lemmers A, Moreno C, Gustot T, Marechal R, Degre D, et al. (2009) The interleukin-17 pathway is involved in human alcoholic liver disease. Hepatology 49: 646-657.
19. Wilson NJ, Boniface K, Chan JR, McKenzie BS, Blumenschein WM, et al. (2007) Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nat Immunol 8: 950-957. Epub 2007 Aug 2005.
20. Guo W, Luo C, Wang C, Zhu Y, Wang X, et al. (2012) Protection against Th17 Cells Differentiation by an Interleukin-23 Receptor Cytokine-Binding Homology Region. PLoS One 7: e45625 doi:45610.41371/journal.pone.0045625. Epub 0042012 Sep 0045619.
21. Maddrey WC, Boitnott JK, Bedine MS, Weber FL Jr, Mezey E, et al. (1978) Corticosteroid therapy of alcoholic hepatitis. Gastroenterology 75: 193-199.
22. Rasmussen TK, Andersen T, Hvid M, Hetland ML, Horslev-Petersen K, et al. (2010) Increased interleukin 21 (IL-21) and IL-23 are associated with increased disease activity and with radiographic status in patients with early rheumatoid arthritis. J Rheumatol 37: 2014-2020. Epub 2010 Aug 2013.
23. Korn T, Bettelli E, Oukka M, Kuchroo VK, (2009) IL-17 and Th17 Cells. Annu Rev Immunol 27: 485-517.
24. Zhang Y, Cobleigh MA, Lian JQ, Huang CX, Booth CJ, et al. (2011) A proinflammatory role for interleukin-22 in the immune response to hepatitis B virus. Gastroenterology 141: 1897-1906. Epub 2011 Jun 1825.
25. Foster RG, Golden-Mason L, Rutebemberwa A, Rosen HR, (2011) Interleukin (IL)-17/IL-22-Producing T cells Enriched Within the Liver of Patients with Chronic Hepatitis C Viral (HCV) Infection. Dig Dis Sci 20: 20.
26. Jiang R, Tan Z, Deng L, Chen Y, Xia Y, et al. (2011) Interleukin-22 promotes human hepatocellular carcinoma by activation of STAT3. Hepatology 54: 900-909 doi:910.1002/hep.24486. Epub 22011 Aug 24488.
27. Xiang X, Gui H, King NJ, Cole L, Wang H, et al. (2011) IL-22 and non-ELR-CXC chemokine expression in chronic hepatitis B virus-infected liver. Immunol Cell Biol 27: 79.
28. Zhao L, Tang Y, You Z, Wang Q, Liang S, et al. (2011) Interleukin-17 contributes to the pathogenesis of autoimmune hepatitis through inducing hepatic interleukin-6 expression. PLoS One 6: e18909.
29. Harada K, Shimoda S, Sato Y, Isse K, Ikeda H, et al. (2009) Periductal interleukin-17 production in association with biliary innate immunity contributes to the pathogenesis of cholangiopathy in primary biliary cirrhosis. Clin Exp Immunol 157: 261-270.
30. Zhang JY, Zhang Z, Lin F, Zou ZS, Xu RN, et al. (2010) Interleukin-17-producing CD4(+) T cells increase with severity of liver damage in patients with chronic hepatitis B. Hepatology. 51: 81-91.
31. Theodossi A, Eddleston AL, Williams R, (1982) Controlled trial of methylprednisolone therapy in severe acute alcoholic hepatitis. Gut 23: 75-79.
32. Akriviadis E, Botla R, Briggs W, Han S, Reynolds T, et al. (2000) Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial. Gastroenterology 119: 1637-1648.
33. Forrest EH, Evans CD, Stewart S, Phillips M, Oo YH, et al. (2005) Analysis of factors predictive of mortality in alcoholic hepatitis and derivation and validation of the Glasgow alcoholic hepatitis score. Gut 54: 1174-1179.
34. Whitfield K, Rambaldi A, Wetterslev Jr, Gluud C (2009) Pentoxifylline for alcoholic hepatitis. Cochrane Database of Systematic Reviews. Chichester, UK: John Wiley & Sons, Ltd.
35. Radaeva S, Sun R, Pan HN, Hong F, Gao B, (2004) Interleukin 22 (IL-22) plays a protective role in T cell-mediated murine hepatitis: IL-22 is a survival factor for hepatocytes via STAT3 activation. Hepatology 39: 1332-1342.
36. Xing WW, Zou MJ, Liu S, Xu T, Gao J, et al. (2011) Hepatoprotective effects of IL-22 on fulminant hepatic failure induced by d-galactosamine and lipopolysaccharide in mice. Cytokine 56: 174-179. Epub 2011 Aug 2016.
37. Yang L, Zhang Y, Wang L, Fan F, Zhu L, et al. (2010) Amelioration of high fat diet induced liver lipogenesis and hepatic steatosis by interleukin-22. J Hepatol 53: 339-347. Epub 2010 Apr 2021.
38. Kong X, Feng D, Wang H, Hong F, Bertola A, et al. (2012) Interleukin-22 induces hepatic stellate cell senescence and restricts liver fibrosis. Hepatology 2: 25744.
39. Dudakov JA, Hanash AM, Jenq RR, Young LF, Ghosh A, et al. (2012) Interleukin-22 Drives Endogenous Thymic Regeneration in Mice. Science 1: 1.
40. Wei CC, Ho TW, Liang WG, Chen GY, Chang MS, (2003) Cloning and characterization of mouse IL-22 binding protein. Genes Immun 4: 204-211.
41. Wolk K, Witte E, Hoffmann U, Doecke WD, Endesfelder S, et al. (2007) IL-22 induces lipopolysaccharide-binding protein in hepatocytes: a potential systemic role of IL-22 in Crohn's disease. J Immunol 178: 5973-5981.
42. Mathurin P, O'Grady J, Carithers RL, Phillips M, Louvet A, et al. (2011) Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis: meta-analysis of individual patient data. Gut 60: 255-260. Epub 2010 Oct 2012.
43. Gao B, Bataller R (2011) Alcoholic liver disease: pathogenesis and new therapeutic targets. Gastroenterology 141: 1572-1585. Epub 2011 Sep 1512.